Cough monitoring, namely for the measurement of cough frequency, has seen increased interest and use in clinical trials to provide a greater understanding of treatment effects on subjects’ cough. As sponsors and researchers evaluate cough monitoring technologies for...
At this year’s ATS conference, Strados Labs was proud to host the session, “Tuning In To Cough in Pulmonary Fibrosis: How Should We Address the Gap?” presented by Dr. Toby Maher, Professor of Clinical Medicine at the Keck School of Medicine, USC. The talk focused on...
Dr. Peter Cho’s section focused on cough in ILDs (on behalf of Strados Labs) from 28:52 – 39:40. Interstitial lung disease (ILD) represents a diverse group of disorders characterized by infiltration of lung parenchyma with extracellular matrix, leading to...
Cough monitoring has emerged as an increasingly common practice in research studies and drug development in recent years to objectively measure changes in subjects’ cough. As drug developers consider including cough frequency as an endpoint in their studies,...
In research studies and healthcare settings, minimizing patient burden is essential for reliable data collection with wearables and devices. At Strados Labs, we understand the importance of these factors with the RESP® Biosensor, which is designed to continuously...
Increased importance has been placed in recent years on the ability of idiopathic pulmonary fibrosis (IPF) treatments to impact how patients feel and function, beyond survival (Raghu, et al., 2024). In IPF, one of the most burdensome symptoms impacting how patients...
